Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-27

FDA Approved: DORZOLAMIDE AND TIMOLOL — Supplemental Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approval of a supplemental application for the dorzolamide and timolol combination ophthalmic solution from Leading Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide and Timolol (Dorzolamide hydrochloride and timolol maleate ophthalmic solution)

Snippet

SUPPL AP for DORZOLAMIDE AND TIMOLOL (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION)